OBJECTIVE: The aim of our study was to examine the predictive value of the anatomic severity grading (ASG) score for @entity1028 ( @entity1028 ) on implant-related complications, systemic complications, and mortality at 30-day and midterm, defined as 2  years, follow-up assessments. METHODS: @entity1 who underwent @entity439 repair for infrarenal @entity1028 between 2009 and 2012 were retrospectively reviewed, and ASG scores were calculated from three-dimensonal computed tomography reconstructions. Two independent @entity1 groups were created: those with a low ASG score (score  <14) and those with a high ASG score (score >= 14). RESULTS: We identified 190 @entity1 (77% male), with a mean age of 73  years, and 84% Caucasian, with 104 @entity1 in the low-score group and 86 in the high-score group. Within 30  days of the index @entity439 repair, 10 implant-related complications occurred in six @entity1 (3%) and 25 systemic complications in 18 (9%). The incidence of 30-day implant-related complications was not significantly different between the low-score group (2 [2%]) and the high-score group (4 [5%]; P  = .41). The incidence of @entity1 with 30-day systemic complications was significantly different between the low-score group (5 [5%]) and the high score group (13 [15%]; P  = .023). A composite end point of combined implant-related and systemic complications at 30  days showed there was a statistically significant difference between the low-score (7  [7%]) and high-score group (17 [20%]; P  = .007). At a midterm follow up of 26  months (range, 1-64  months), implant-related complications occurred in 21 @entity1 (11%), and systemic complications occurred in 29 (15%). The incidence of implant-related complications was significantly different between the low-score group (7 [7%]) and the high-score group (14 [16%]; P  = .037). The incidence of midterm systemic complications was significantly different between the low-score group (11 [11%]) and the high-score group (18 [21%]; P  = .048). A composite end point of combined implant-related and systemic complications at midterm follow-up resulted in a statistically significant difference between the low-score group (16 [15%]) and the high-score group (26 [30%]; P  = .014). Kaplan-Meier analysis revealed that the low-score group had fewer overall complications (combined implant-related and systemic) at 1  year (14% vs 34%) and 2  years (15% vs 45%) compared with the high-score group (P  < .001). The low-scoring group also had significantly higher survival at 1  year (96% vs 86%) and 2  years (88% vs 84%) compared with the high-score group (P  = .047). CONCLUSIONS: The AAA ASG score can be used to predict @entity1 at risk for midterm implant-related complications, 30-day and midterm systemic complications, and all-cause mortality.

XXXX anatomic severity grading score predicts implant-related complications, systemic complications, and mortality.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity439 :: ('MESH:D000783', 'Disease') :: ['endovascular aneurysm'] @entity1028 :: ('MESH:D017544', 'Disease') :: ['abdominal aortic aneurysms', 'AAAs']
@entity1028 :: (MESH:D017544,Disease) :: ['Abdominal aortic aneurysm']
